171 related articles for article (PubMed ID: 8396258)
1. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination.
Hollenberg SM; Cheng PF; Weintraub H
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8028-32. PubMed ID: 8396258
[TBL] [Abstract][Full Text] [Related]
2. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.
Muscat GE; Rea S; Downes M
Nucleic Acids Res; 1995 Apr; 23(8):1311-8. PubMed ID: 7753622
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
Downes M; Carozzi AJ; Muscat GE
Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
[TBL] [Abstract][Full Text] [Related]
4. The MRF4 activation domain is required to induce muscle-specific gene expression.
Mak KL; To RQ; Kong Y; Konieczny SF
Mol Cell Biol; 1992 Oct; 12(10):4334-46. PubMed ID: 1328851
[TBL] [Abstract][Full Text] [Related]
5. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene.
Tamir Y; Bengal E
Oncogene; 1998 Jul; 17(3):347-56. PubMed ID: 9690516
[TBL] [Abstract][Full Text] [Related]
6. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
[TBL] [Abstract][Full Text] [Related]
7. Activation of myoD gene transcription by 3,5,3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors.
Muscat GE; Mynett-Johnson L; Dowhan D; Downes M; Griggs R
Nucleic Acids Res; 1994 Feb; 22(4):583-91. PubMed ID: 8127707
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of cardiac MLC-2 promoter by MyoD in 10T1/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site.
Goswami SK; Siddiqui MA
Cell Mol Biol Res; 1995; 41(3):199-205. PubMed ID: 8589760
[TBL] [Abstract][Full Text] [Related]
9. Muscle-specific transcriptional activation by MyoD.
Weintraub H; Dwarki VJ; Verma I; Davis R; Hollenberg S; Snider L; Lassar A; Tapscott SJ
Genes Dev; 1991 Aug; 5(8):1377-86. PubMed ID: 1651276
[TBL] [Abstract][Full Text] [Related]
10. Repression of c-fos promoter by MyoD on muscle cell differentiation.
Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
12. Involvement of myogenic regulator factors during fusion in the cell line C2C12.
Dedieu S; Mazères G; Cottin P; Brustis JJ
Int J Dev Biol; 2002 Mar; 46(2):235-41. PubMed ID: 11934152
[TBL] [Abstract][Full Text] [Related]
13. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer.
Lassar AB; Buskin JN; Lockshon D; Davis RL; Apone S; Hauschka SD; Weintraub H
Cell; 1989 Sep; 58(5):823-31. PubMed ID: 2550138
[TBL] [Abstract][Full Text] [Related]
14. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
Johnson JE; Birren SJ; Saito T; Anderson DJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3596-600. PubMed ID: 1314394
[TBL] [Abstract][Full Text] [Related]
15. The levels of vascular smooth as well as skeletal muscle actin mRNAs differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):903-13. PubMed ID: 1477607
[TBL] [Abstract][Full Text] [Related]
16. The levels of vascular smooth as well as skeletal muscle actin mRNAS differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol; 1992 Aug; 38(5):485-504. PubMed ID: 1468109
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.
Tapscott SJ; Thayer MJ; Weintraub H
Science; 1993 Mar; 259(5100):1450-3. PubMed ID: 8383879
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical decrease in myf-5 messenger RNA levels during induction of myogenic differentiation by insulin-like growth factors.
Mangiacapra FJ; Roof SL; Ewton DZ; Florini JR
Mol Endocrinol; 1992 Dec; 6(12):2038-44. PubMed ID: 1337140
[TBL] [Abstract][Full Text] [Related]
19. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
20. A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription.
Santalucía T; Moreno H; Palacín M; Yacoub MH; Brand NJ; Zorzano A
J Mol Biol; 2001 Nov; 314(2):195-204. PubMed ID: 11718554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
